Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, Désirée van der Heijde, Maxime Dougados, Ronald van Vollenhoven, Iain B. McInnes, J. W. J. Bijlsma, Gerd R Burmester, Maarten de Wit, Louise Falzon, Robert Landewé
Topics & Concepts
MedicineTofacitinibRheumatoid arthritisAbataceptInternal medicineTocilizumabObservational studyHazard ratioAdalimumabConfidence intervalRituximabLymphomaRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchLymphoma Diagnosis and Treatment